当社グループは 3,000 以上の世界的なカンファレンスシリーズ 米国、ヨーロッパ、世界中で毎年イベントが開催されます。 1,000 のより科学的な学会からの支援を受けたアジア および 700 以上の オープン アクセスを発行ジャーナルには 50,000 人以上の著名人が掲載されており、科学者が編集委員として名高い
。オープンアクセスジャーナルはより多くの読者と引用を獲得
700 ジャーナル と 15,000,000 人の読者 各ジャーナルは 25,000 人以上の読者を獲得
Zhen Huang
Advances in drug delivery systems have revolutionized the field of healthcare by enhancing therapeutic efficacy and improving patient compliance. Traditional drug delivery methods often faced challenges such as poor bioavailability, low solubility, rapid clearance from the body, and inconsistent drug release profiles. However, recent innovations in drug delivery have overcome these limitations, leading to more efficient and targeted treatments. One major advancement in drug delivery is the development of nanotechnology-based systems. Nanoparticles, liposomes, and micelles are engineered to encapsulate drugs, protecting them from degradation and enabling precise delivery to the desired site of action. These nanocarriers can be designed to release the drug in a controlled manner, prolonging its therapeutic effect and reducing the frequency of administration. Furthermore, their small size allows for enhanced cellular uptake, increasing drug concentration at the target site while minimizing side effects on healthy tissues.